Background Whether schizophrenia and bipolar disorder are the clinical outcomes of discrete or shared causative processes is much debated in psychiatry. We aimed to assess genetic and environmental contributions to liability for schizophrenia, bipolar disorder, and their comorbidity.
Introduction
Opinions diff er about whether schizophrenia and bipolar disorder have a common cause. Some think that schizophrenia and bipolar disorder are the clinical outcomes of entirely diff erent processes, whereas others believe in identical processes. Several intermediate and more-complicated hypotheses can also be envisioned whereby, for example, a shared causative risk factor is responsible for part of each disorder. A common cause has been suggested by molecular genetic studies 1 by the existence of an intermediate phenotype (schizoaff ective disorder), which shares diagnostic features of both disorders, and by evidence that similar endophenotypes (eg, brain white-matter density) 2 are associated with both disorders. However, evidence from genetic epidemio logical studies is mixed partly because of small sample sizes. 3, 4 Genome-wide linkage screenings have shown some overlap between schizophrenia and bipolar disorder. 5, 6 One meta-analysis showed genomic regions in common, 7 although a more inclusive meta-analysis suggested that no overlap of the highest-ranking regions for the two disorders existed; 8, 9 a third meta-analysis with genotype data from individual studies did not show strong overlap. 10 However, overlap can arise by chance. If we assume three 500-marker genome scans for schizophrenia and three for bipolar disorder, with a simple simulation model (α=0·05, 10 000 simulations) with no true genetic eff ects, the absence of positional overlap between any schizophrenia scan and any bipolar disorder scan would be uncommon (7%), one overlap would happen frequently (18%), and multiple overlaps would predominate (75%). Therefore, because there are 20 schizophrenia and 18 bipolar disorder genome-wide linkage scans, 8, 9 substantial overlap across studies is to be expected purely by chance. An additional diffi culty is that individuals with schizoaff ective disorder are generally classifi ed as aff ected in genetic studies of each syndrome. 8, 9 Some workers have investigated the genetic asso ciation of markers in candidate genes in both schizo phrenia and bipolar disorder. [11] [12] [13] These studies provide evidence for an overlap in genetic susceptibility between the two disorders, and for the possibility of specifi c associations between genotype and type of pathology, 1 although interpretations should be drawn with caution. 14 Studies that are based on diagnostic resemblance in familial relationships can be helpful to understand the sources of overlap between two disorders. One twin study 15 is usually cited as supporting the overlap between schizophrenia and bipolar disorder, although its conclusions are qualifi ed by a small sample size and assessment of mania, rather than bipolar disorder per se. A small Finnish study 16 of 26 twins with bipolar disorder did not identify any co-twin with schizophrenia. High-quality family studies have suggested that schizophrenia and bipolar disorder do not overlap. 3, 4 One study 5 stated "there is no increased risk for bipolar disorder among fi rst-degree relatives of schizophrenia probands…nor is there increased risk for schizophrenia among fi rst-degree relatives of bipolar disorder probands". However, in a large population-based study in Denmark, 17 risk of bipolar disorder was associated with a history of schizophrenia in parents and siblings.
Because the relation between schizophrenia and bipolar disorder is unclear, we have used population-based registries that contain the entire Swedish population to assess the degree of genetic overlap between these two disorders.
Methods

National registers
We linked two Swedish national registers, using the unique, individual Swedish national registration number, which was introduced in 1947 and is assigned at birth.
The multi-generation register contains information about fi rst-degree relatives. 18 This register includes entries for an index person along with their biological and adoptive parents. To be in the register, an index person had to be registered in Sweden between Jan 1, 1961, and Dec 31, 2002 , and to have been born between Jan 1, 1932, and Dec 31, 2002 . The father was assumed to be the husband of the mother at the time of birth or the person acknowledged as the father by unmarried mothers.
The hospital discharge register contains all public psychiatric inpatient admissions in Sweden since 1973. Every record has admission and discharge dates, the main discharge diagnosis, and up to eight secondary diagnoses assigned by the treating physician according to the International Classifi cation of Diseases (ICD) system. [19] [20] [21] We obtained information about all psychiatric admissions between 1973 and 2004.
Disease classifi cations
Patients with schizophrenia were defi ned as individuals identifi ed in the hospital discharge register having at least two inpatient admissions with a discharge diagnosis of schizophrenia (ICD-8 295, ICD-9 295, ICD-10 F20, with latent schizophrenia, 295.5 and 295F, excluded). The criterion of at least two inpatient admissions was chosen to increase diagnostic precision, and in a previous study gave almost identical estimates of familial risks to those from published work. 22 Similarly, we defi ned bipolar disorder as two or more inpatient admissions for a core bipolar diagnosis (296 and F31).
Both diseases were diagnosed with a non-hierarchical diagnostic structure. Thus, an individual could have both schizophrenia and bipolar disorder, if the person has been diagnosed at least twice with each disease. To avoid possible misclassifi cation between schizophrenia and bipolar disorder, admissions with the diagnoses of schizoaff ective disorder (ICD codes 295.7, 295H, F25.X) were not taken into account, and 3563 individuals were therefore excluded.
Statistical analysis
The risk of disease in relatives of a proband with that disease was compared with the risk in relatives of fi ve unaff ected individuals matched by sex and year of birth for each member in the pair (for adoptive relationships, indi viduals were matched with 5-year age-band intervals). To ensure equal follow-up time, we additionally re quired that the relatives of probands and controls were alive and had not been admitted to psychiatric care in Sweden by the date the proband was fi rst admitted. Data were analysed with a conditional logistic regression model with the PROC TPHREG procedure in SAS (version 9.1.3). 23 Because several possibly correlated pairs of relatives from every family could be included in an analysis, a robust sandwich estimator was used to adjust for the correlated data when calculating the confi dence intervals.
To separate genetic and environmental contributions to liability for schizophrenia and bipolar disorder, we analysed outcomes from diff erent family types: nuclear, paternal half-sibling, and maternal half-sibling families. To reduce complexity in families with half-siblings, marriages of the index parent were restricted to two spouses, which excluded 8% of the half-sibling families. When more than two children were available, we analysed only the oldest two full-siblings from a nuclear family and the oldest two half-siblings from a half-sibling family. Our data include 1 984 182 nuclear families, 172 073 paternal half-sibling families, and 161 409 maternal half-sibling families.
We used a multivariate generalised linear mixed model with probit link. 24 The probability for an individual to have a disease is measured by a latent risk variable R, which corresponds to the area under the standard normal curve-ie, a small value of R indicates a small probability. Our model specifi ed R as the sum of several eff ects, including family-member type (father, mother, or children), additive genetic (A sz , A bp ), adult shared environ mental (F sz , F bp ), and childhood shared environmental (C sz , C bp ) eff ects, along with a common non-shared environmental eff ect for both schizophrenia and bipolar disorder (E). For schizophrenia and bipolar disorder, our models were:
where I f , I m , and I c are indicator variables for father, mother, and children; β f , β m , and β c are fi xed variables associated with disease prevalence for respective family members. The random eff ects A, F, C, and E are assumed to be normally distributed, with mean zero and a unique variance component for each term. Thus, we have variance components σ² sza , σ² bpa , σ² szf , σ² bpf , σ² szc , and σ² bpc . The non-shared eff ect E is normal, with mean zero and variance σ² e .
For each disorder, we assumed that the random eff ects are independent between families, but dependent within families (table 1) . The model includes cross-disease covariances: σ szbpa is the additive-genetic covariance of schizophrenia and bipolar eff ect and, similarly, σ szbpf and σ szbpc are the covariances of adult and childhood environmental eff ects. All parameters were estimated simultaneously with the maximum likelihood method, 25 where the likelihood is computed with a fast Monte Carlo integration of the random eff ects. 26 Variance and covariance parameters are reported as proportional contributions to the liability to disease. Confi dence intervals for estimates were obtained with a likelihood-based procedure, 25 corrected for uncertainty due to Monte Carlo integration. A more thorough description of the bivariate model is provided elsewhere. 27 The study was supported by the Swedish Council for Working Life and Social Research, and the Swedish Research Council. 
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
We identifi ed 9 009 202 unique individuals of known parentage, for whom both parents were alive and living in Sweden after 1973. 35 985 individuals met the criteria for schizophrenia and 40 487 individuals for bipolar disorder. Of those with schizophrenia, 2543 also had bipolar disorder (relative risk [RR] 16·4, 95% CI 15·1-17·7). We have previously shown the recurrence risks for schizophrenia.
22 Table 2 presents these results for parent-off spring and sibling relationships, and extends our previous work by taking into account diff erent types of half-sibling and adoptive relationships, together with the results for bipolar disorder and the familial aggregation of comorbidity between the disorders.
Similar to the results in our previous work, 22 fi rst-degree relatives had increased risk of schizophrenia.
Half-siblings had a signifi cantly increased risk, albeit sub stantially lower than had full-siblings. Adopted children, whose biological parents had schizophrenia, and biological siblings growing up in diff erent families also had an increase in risk of being diagnosed with the same disease. No cases existed in which both an adoptive parent and an adoptee had a diagnosis of schizophrenia.
The risk for bipolar disorder in fi rst-degree relatives of individuals with bipolar disorder was lower than the risk for schizophrenia in fi rst-degree relatives of individuals with that disorder. Otherwise, the familial risks were of similar magnitudes. Adopted children whose biological parents had bipolar disorder had a more than four-fold risk of bipolar disorder.
When the proband had bipolar disorder, their fi rst-degree relatives had a signifi cantly increased risk of schizophrenia (table 2) . Half-siblings also had an increased though non-signifi cant risk as did adoptees when the adoptive parents had bipolar disorder. Results were similar for the risk of bipolar disorder in relatives of probands with schizophrenia (table 2) . No noticeable sex diff erences existed in familial risks (data not shown).
Heritability for schizophrenia was estimated to be 64% (table 3 and fi gure). For bipolar disorder, the estimate was 59%. Shared environmental eff ects were small but signifi cant for both disorders.
Comorbidity was mainly due to additive genetic eff ects common to both disorders. The genetic correlation (r g ) was 0·60. Unique genetic eff ects for schizophrenia that were not in common with bipolar disorder accounted for 48% of the genetic variance in schizophrenia (and for 31% in bipolar disorder) (fi gure).
The use of a non-hierarchical defi nition of syndromes might be questioned. We therefore investigated the sibling risk of developing a disorder when both probands and siblings with comorbid schizophrenia and bipolar disorder were excluded. The risk for bipolar disorder in siblings of probands with schizophrenia was signifi cantly increased (2·7 [2·3-3·1]). We also did the model-fi tting analyses with hierarchical diagnoses, in which individuals with two or more schizophrenia diagnoses were classifi ed as having schizophrenia (and not bipolar disorder, even if they have had two or more such diagnoses). According to this analysis, estimates were almost the same (table 3) , other than for non-shared environmental eff ects, which did not contribute to comorbidity (because an individual could not be diagnosed with both disorders).
Another issue is how to treat individuals with schizoaff ective disorder. To avoid possible mis classifi cation between schizophrenia and bipolar disorder, we excluded admissions with diagnosis of schizoaff ective disorder in our main analyses. However, when we classifi ed schizoaff ective cases as schizophrenia, the results were similar, but familial risks were higher when schizoaff ective cases were included than when they were not (webtables 1 and 2).
Discussion
In this study of more than 2 million Swedish families, we found evidence of a substantial genetic association between schizophrenia and bipolar disorder. All classes of biological relatives of probands with bipolar disorder had increased risk for schizophrenia, and the genetic correlation (ie, the correlation between the genetic eff ects that determine the liabilities for the two disorders) was 0·60. Furthermore, adopted children whose biological parents had one of these disorders had signifi cant increase in risks for the other disorder. These results are in line with previous molecular genetic studies, 1 and twin, 15 and family 17 studies that suggest a common genetic contribution for schizo phrenia and bipolar disorder, even if they are discordant with some family studies in which clinicians have reviewed the personal interview, and hospital and outpatient records of the course of illness. 3, 4 Patients with one diagnosis sometimes evolve into the other diagnosis; whether this change is due to misclassifi cation at fi rst diagnosis or to the fact that the individual has both disorders is not clear. If patients with both disorders are misclassifi ed, our approach with non-hierarchical diagnoses would give artifi cially increased associations. However, when we analysed sibling risks without comorbidity, a signifi cant increase in risk remained. Furthermore, in the analyses with hierarchical diagnoses, estimates were almost the same. Thus, schizophrenia and bipolar disorder share common genetic causes. Nonetheless, a considerable proportion of genetic variance is not in common with the other disorder, both for schizophrenia and bipolar disorder. Thus, some genes are probably associated with the risk for both disorders and some with the risk for only one disorder. This possibility should be considered in future research and in clinical settings.
Estimated heritability for schizophrenia was 64%, which was lower than that (81%) in a meta-analysis of twin studies. 28 Furthermore, estimated heritability for bipolar disorder was 59%, which was also lower than previous estimates (80%) based on twin studies. 16 An issue in twin studies is their low power to estimate heritability for rare diseases. Also, they are less sensitive to age and non-additive genetic eff ects than are family studies. Nonetheless, both types of studies show that schizophrenia and bipolar disease are heritable (estimated heritability of 60-80% of the liabilities).
Shared environmental eff ects on both disorders and their comorbidity are small but signifi cant, accounting for 3-6% of the variance and covariance, which corroborates the results from the meta-analysis 28 of twin studies on schizophrenia. Twin studies have limited power to detect shared environmental eff ects, especially for binary traits. 29 We suggest caution when drawing conclusions for psychiatric conditions, when small samples are used.
Non-shared environmental eff ects contributed to comorbidity (~30%). By contrast with non-shared environmental eff ects estimated in the univariate analyses, the estimate of the comorbidity due to non-shared environmental eff ects should be free from measure ment error. One possibility is that perinatal eff ects are a candidate mechanism. 30 The strength of our data is the national coverage of all inpatient treatment facilities, including care in psychiatric and somatic clinics. Similar to most developed nations, inpatient psychiatric care has been reduced in Sweden over the past two decades. However, a recent study 31 showed that, although the total number of days spent in psychiatric beds in Sweden between 1994 and 2003 fell dramatically, the number of admissions scarcely changed. A limitation of this study is the use of non-standardised diagnoses made by diff erent clinicians with diff erent opinions. This drawback is typical for population-based studies of this kind. Nevertheless, validation studies confi rmed a low number of false-positive diagnoses. 32, 33 There was 94% agreement between register diagnoses of schizophrenia and research diagnoses based on semi-structured interviews and medical records. 33 The validity of a discharge diagnosis of bipolar disorder has not been assessed, but it is likely to be high as for schizophrenia in view of the conservative and restrictive diagnostic culture for psychoses in Sweden. A few cases may have been treated entirely outside hospital. Another limitation with the bipolar diagnoses is that the strict ICD-10 defi nitions were only available for the past 7 years of this 31-year study.
Diagnostic bias could have happened if diagnostic assessments by physicians were infl uenced by knowledge of family psychiatric history; this would have probably reduced variation across diagnoses. Our data for adoptive relationships are not prone to such bias.
Cases were individuals with narrow diagnoses of schizophrenia and bipolar disorder. By restricting our analyses to at least two admissions, we increased specifi city of the register diagnoses. Furthermore, we chose a conservative approach by excluding schizoaff ective disorder, which is symptomatically intermediate between schizophrenia and bipolar disorder. However, when we repeated the analyses including schizoaff ective cases, results were similar to those obtained in the analysis without these cases.
Overall, similar to recent results from molecular genetic studies, 1 we found evidence that schizophrenia and bipolar disorder partly share common genetic causes, which challenges the nosological dichotomy between schizophrenia and bipolar disorder. These results should inform the diagnostic classifi cation used in linkage and association studies, and encourage further research for endophenotypic traits shared between these two disorders. Within clinical practice, the underlying structure of psychosis and the knowledge of the common causes of these disorders might be benefi cial for treatment options and development of psychosis medication.
